Results 181 to 190 of about 10,221 (208)
Some of the next articles are maybe not open access.
Annual Review of Medicine, 1989
Prolactinomas are the most common of the hormone-secreting pituitary tumors and must be distinguished from nonsecreting tumors causing hyperprolactinemia by hypothalamic or stalk dysfunction. For both micro- and macroadenomas, dopamine agonists appear to be the treatment of choice, transsphenoidal surgery being reserved for nonresponders.
openaire +2 more sources
Prolactinomas are the most common of the hormone-secreting pituitary tumors and must be distinguished from nonsecreting tumors causing hyperprolactinemia by hypothalamic or stalk dysfunction. For both micro- and macroadenomas, dopamine agonists appear to be the treatment of choice, transsphenoidal surgery being reserved for nonresponders.
openaire +2 more sources
Endocrinology and Metabolism Clinics of North America
Prolactinomas are the most common type of pituitary adenomas and the most common cause of hyperprolactinemia. There are several pitfalls in the evaluation of hyperprolactinemia, which should be recognized as they affect management decisions. Medical therapy with dopamine agonists is the first-line treatment for prolactinomas. Transsphenoidal surgery is
Catherine D. Zhang +1 more
openaire +2 more sources
Prolactinomas are the most common type of pituitary adenomas and the most common cause of hyperprolactinemia. There are several pitfalls in the evaluation of hyperprolactinemia, which should be recognized as they affect management decisions. Medical therapy with dopamine agonists is the first-line treatment for prolactinomas. Transsphenoidal surgery is
Catherine D. Zhang +1 more
openaire +2 more sources
Archives of Internal Medicine, 1979
In the past ten years, hyperprolactinemia has been implicated as a possible cause of several common medical problems. One of the first recognized was the so-called amenorrhea-galactorrhea syndrome. Subsequently it was learned that not all patients with elevated prolactin levels have galactorrhea 1 (only about 20% of hyperprolactinemic women and even ...
openaire +2 more sources
In the past ten years, hyperprolactinemia has been implicated as a possible cause of several common medical problems. One of the first recognized was the so-called amenorrhea-galactorrhea syndrome. Subsequently it was learned that not all patients with elevated prolactin levels have galactorrhea 1 (only about 20% of hyperprolactinemic women and even ...
openaire +2 more sources
Ossified Prolactinoma: Case Report
Neurosurgery, 1987Abstract The authors report a case of ossified prolactinoma that was identified as a calcified nodule on the roentgenograms. Histologically, the ossified tissues were diffuse, and the osteoid was mineralized in various degress, subsequently forming bones. Adenoma cells were sparse among the ossified tissues.
K, Mukada +5 more
openaire +2 more sources
Przeglad lekarski, 2009
Prolactin-secreting tumours (prolactinomas) are benign neoplasms constituting about 40 percent of all pituitary tumours. The incidence of these tumours varies with age and sex, occurring most frequently in females between 20 and 40-years-old. The clinical symptoms of prolactinomas are menstrual dysfunction and galactorrhea in women and loss of libido ...
Robert, Krysiak +3 more
openaire +1 more source
Prolactin-secreting tumours (prolactinomas) are benign neoplasms constituting about 40 percent of all pituitary tumours. The incidence of these tumours varies with age and sex, occurring most frequently in females between 20 and 40-years-old. The clinical symptoms of prolactinomas are menstrual dysfunction and galactorrhea in women and loss of libido ...
Robert, Krysiak +3 more
openaire +1 more source
Prolactinomas are benign pituitary tumors characterized by excessive secretion of prolactin. While more common in females, these tumors can also significantly impact male patients, leading to symptoms such as hypogonadism, infertility and gynecomastia.
openaire +1 more source
openaire +1 more source